tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
SMMT Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsSMMT Upcoming Earnings Report: What to Expect?
3d ago
Summit Therapeutics: Ivonescimab’s De-Risked Regulatory Path and Multi-Indication Upside Support $40 Target and Buy Rating
Premium
Ratings
Summit Therapeutics: Ivonescimab’s De-Risked Regulatory Path and Multi-Indication Upside Support $40 Target and Buy Rating
22d ago
Summit Therapeutics’ Ivonescimab BLA Accepted by FDA
Premium
Company Announcements
Summit Therapeutics’ Ivonescimab BLA Accepted by FDA
26d ago
Summit Therapeutics: Ivonescimab OS Readout, Regulatory Milestones, and GSK Partnership Underpin Reaffirmed Buy and $40 Target
PremiumRatingsSummit Therapeutics: Ivonescimab OS Readout, Regulatory Milestones, and GSK Partnership Underpin Reaffirmed Buy and $40 Target
1M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
Summit Therapeutics Expands Ivonescimab Program With GSK Collaboration
Premium
Company Announcements
Summit Therapeutics Expands Ivonescimab Program With GSK Collaboration
1M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
3M ago
Short Report: Sezzle short interest at record high
Premium
The Fly
Short Report: Sezzle short interest at record high
3M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100